118 related articles for article (PubMed ID: 25276086)
1. Treatment of serous retinal detachment associated with choroidal ischemia with intravitreal bevacizumab following brain surgery.
Cho YJ; Choi EY; Koh HJ; Lee SC; Kim M
Korean J Ophthalmol; 2014 Oct; 28(5):424-6. PubMed ID: 25276086
[No Abstract] [Full Text] [Related]
2. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
3. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab.
Barkmeier AJ; Kadikoy H; Holz ER; Carvounis PE
Eur J Ophthalmol; 2011; 21(4):506-8. PubMed ID: 21240857
[TBL] [Abstract][Full Text] [Related]
4. Treatment of macular serous neuroretinal detachment in tilted disk syndrome: report of 3 cases.
Donati MC; Miele A; Abbruzzese G; Giuntoli M; Giansanti F; Menchini U
Eur J Ophthalmol; 2013; 23(2):267-70. PubMed ID: 23225087
[TBL] [Abstract][Full Text] [Related]
5. SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Zatreanu L; Freund KB; Leong BCS; Yu HG; Teke MY; Yzer S; Sadda SR; Sarraf D
Retina; 2020 Aug; 40(8):1456-1470. PubMed ID: 31613838
[TBL] [Abstract][Full Text] [Related]
6. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
9. FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
Hwang H; Kim JY; Kim KT; Chae JB; Kim DY
Retina; 2020 Sep; 40(9):1724-1733. PubMed ID: 31584559
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of central serous chorioretinopathy following PASCAL photocoagulation.
Yang HS; Park SH
Can J Ophthalmol; 2013 Jun; 48(3):e42-3. PubMed ID: 23769790
[No Abstract] [Full Text] [Related]
11. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
Battaglia Parodi M; Iacono P; Bandello F
Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Anti-vascular Endothelial Growth Factor Treatment for Foveal Serous Retinal Detachment Associated with Inferior Staphyloma.
Lee EK; Yu HG
Korean J Ophthalmol; 2019 Jun; 33(3):228-237. PubMed ID: 31179654
[TBL] [Abstract][Full Text] [Related]
13. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
15. Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.
Kim KS; Lee WK
Jpn J Ophthalmol; 2011 Jul; 55(4):370-377. PubMed ID: 21647565
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
17. Retinal degeneration and persistent serous detachment in the absence of active choroidal neovascularization in pseudoxanthoma elasticum.
Hansen MS; Klefter ON; Larsen M
Acta Ophthalmol; 2014 Mar; 92(2):e156-7. PubMed ID: 24033986
[No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion.
Cinal A; Ziemssen F; Bartz-Schmidt KU; Gelisken F
Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):513-20. PubMed ID: 21053008
[TBL] [Abstract][Full Text] [Related]
19. Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia.
Xu LT; Courtney RJ; Ehlers JP
Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):262-5. PubMed ID: 25707055
[TBL] [Abstract][Full Text] [Related]
20. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NAIVE IDIOPATHIC CHOROIDAL NEOVASCULARIZATION: A Comparative Study.
Sudhalkar A; Yogi R; Chhablani J
Retina; 2015 Jul; 35(7):1368-74. PubMed ID: 25830696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]